Shiraz E-Medical Journal

Published by: Kowsar

Treatment Adherence in Patients with Hypertension: A Cross Sectional Study from Southeast of Iran

Negar Sadeghi 1 and Habibeh Ahmadipour 2 , *
Authors Information
1 Community and Family Medicine Department, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran
2 Social Determinants of Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
Article information
  • Shiraz E-Medical Journal: 20 (3); e74125
  • Published Online: September 24, 2018
  • Article Type: Research Article
  • Received: April 30, 2018
  • Revised: August 8, 2018
  • Accepted: August 18, 2018
  • DOI: 10.5812/semj.74125

To Cite: Sadeghi N, Ahmadipour H. Treatment Adherence in Patients with Hypertension: A Cross Sectional Study from Southeast of Iran, Shiraz E-Med J. Online ahead of Print ; 20(3):e74125. doi: 10.5812/semj.74125.

Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. World Health Organization. A global brief on hypertension. 2018. Available from:
  • 2. Cabral AC, Castel-Branco M, Caramona M, Fernandez-Llimos F, Figueiredo IV. Developing an adherence in hypertension questionnaire short version: MUAH-16. J Clin Hypertens (Greenwich). 2018;20(1):118-24. doi: 10.1111/jch.13137. [PubMed: 29171719].
  • 3. Villalva CM, Alvarez-Muino XLL, Mondelo TG, Fachado AA, Fernandez JC. Adherence to treatment in hypertension. Adv Exp Med Biol. 2017;956:129-47. doi: 10.1007/5584_2016_77. [PubMed: 27757938].
  • 4. Agbor VN, Takah NF, Aminde LN. Prevalence and factors associated with medication adherence among patients with hypertension in sub-Saharan Africa: Protocol for a systematic review and meta-analysis. BMJ Open. 2018;8(3). e020715. doi: 10.1136/bmjopen-2017-020715. [PubMed: 29549213]. [PubMed Central: PMC5857663].
  • 5. Al-Daken LI, Eshah NF. Self-reported adherence to therapeutic regimens among patients with hypertension. Clin Exp Hypertens. 2017;39(3):264-70. doi: 10.1080/10641963.2016.1247164. [PubMed: 28448187].
  • 6. Natarajan N, Putnam W, Van Aarsen K, Beverley Lawson K, Burge F. Adherence to antihypertensive medications among family practice patients with diabetes mellitus and hypertension. Can Fam Physician. 2013;59(2):e93-e100. [PubMed: 23418264]. [PubMed Central: PMC3576963].
  • 7. Iranian National Committee for NCDs Prevention and Control. National action plan for prevention and control of non communicable diseases and the related risk factors in the Islamic Republic of Iran 2015-2025. Tehran: AFTAB-E-ANDISHE; 2015.
  • 8. Sarayani A, Jahangard-Rafsanjani Z, Hadjibabaie M, Ahmadvand A, Javadi M, Gholami K. A comprehensive review of adherence to diabetes and cardiovascular medications in Iran; implications for practice and research. J Diabetes Metab Disord. 2013;12(1):57. doi: 10.1186/2251-6581-12-57. [PubMed: 24360356]. [PubMed Central: PMC3891984].
  • 9. Dehghan M, Dehghan-Nayeri N, Iranmanesh S. Translation and validation of the Persian version of the treatment adherence questionnaire for patients with hypertension. ARYA Atheroscler. 2016;12(2):76-86. [PubMed: 27429627]. [PubMed Central: PMC4933746].
  • 10. Nayeri ND, Dehghan M, Iranmanesh S. Being as an iceberg: hypertensive treatment adherence experiences in southeast of Iran. Glob Health Action. 2015;8:28814. doi: 10.3402/gha.v8.28814. [PubMed: 26395925]. [PubMed Central: PMC4579246].
  • 11. Dehghan M, Nayri N, Iranmanesh S. Development and validation of hypertensive treatment adherence scale [Dissertation]. Kerman University of Medical Science; 2015.
  • 12. Dehghan M, Nayeri ND, Karimzadeh P, Iranmanesh S. Psychometric properties of the Persian version of the Morisky medication adherence scale-8. Br J Med Med Res. 2015;9(9):1-10. doi: 10.9734/bjmmr/2015/17345.
  • 13. Lee WY, Ahn J, Kim JH, Hong YP, Hong SK, Kim YT, et al. Reliability and validity of a self-reported measure of medication adherence in patients with type 2 diabetes mellitus in Korea. J Int Med Res. 2013;41(4):1098-110. doi: 10.1177/0300060513484433. [PubMed: 23860015].
  • 14. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10(5):348-54. [PubMed: 18453793]. [PubMed Central: PMC2562622].
  • 15. Moharamzad Y, Saadat H, Nakhjavan Shahraki B, Rai A, Saadat Z, Aerab-Sheibani H, et al. Validation of the Persian version of the 8-item Morisky medication adherence scale (MMAS-8) in Iranian hypertensive patients. Glob J Health Sci. 2015;7(4):173-83. doi: 10.5539/gjhs.v7n4p173. [PubMed: 25946926]. [PubMed Central: PMC4802120].
  • 16. Nielsen JO, Shrestha AD, Neupane D, Kallestrup P. Non-adherence to anti-hypertensive medication in low- and middle-income countries: A systematic review and meta-analysis of 92443 subjects. J Hum Hypertens. 2017;31(1):14-21. doi: 10.1038/jhh.2016.31. [PubMed: 27306087].
  • 17. Ruppar TM, Dunbar-Jacob JM, Mehr DR, Lewis L, Conn VS. Medication adherence interventions among hypertensive black adults: A systematic review and meta-analysis. J Hypertens. 2017;35(6):1145-54. doi: 10.1097/HJH.0000000000001260. [PubMed: 28106662].
  • 18. Ahmadipour H, Farajzadegan Z, Kachoei A, Pirdehghan A. Secondary prevention by enhancing adherence in diabetic patients. Int J Prev Med. 2010;1(1):50-5. [PubMed: 21677766]. [PubMed Central: PMC3075488].
  • 19. Abegaz TM, Shehab A, Gebreyohannes EA, Bhagavathula AS, Elnour AA. Nonadherence to antihypertensive drugs: A systematic review and meta-analysis. Medicine (Baltimore). 2017;96(4). e5641. doi: 10.1097/MD.0000000000005641. [PubMed: 28121920]. [PubMed Central: PMC5287944].
  • 20. Mahmoudian A, Zamani A, Tavakoli N, Farajzadegan Z, Fathollahi-Dehkordi F. Medication adherence in patients with hypertension: Does satisfaction with doctor-patient relationship work? J Res Med Sci. 2017;22:48. doi: 10.4103/jrms.JRMS_205_16. [PubMed: 28567067]. [PubMed Central: PMC5426097].
  • 21. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-20. doi: 10.1001/jama.2013.284427. [PubMed: 24352797].
  • 22. Ma C, Chen S, You L, Luo Z, Xing C. Development and psychometric evaluation of the Treatment Adherence Questionnaire for Patients with Hypertension. J Adv Nurs. 2012;68(6):1402-13. doi: 10.1111/j.1365-2648.2011.05835.x. [PubMed: 21954893].
  • 23. He W, Bonner A, Anderson D. Patient reported adherence to hypertension treatment: A revalidation study. Eur J Cardiovasc Nurs. 2016;15(2):150-6. doi: 10.1177/1474515115603902. [PubMed: 26307159].
  • 24. Son YJ, Won MH. Depression and medication adherence among older Korean patients with hypertension: Mediating role of self-efficacy. Int J Nurs Pract. 2017;23(3). doi: 10.1111/ijn.12525. [PubMed: 28194846].
  • 25. Ma C, Chen S, Zhou Y, Huang C. Treatment adherence of Chinese patients with hypertension: A longitudinal study. Appl Nurs Res. 2013;26(4):225-31. doi: 10.1016/j.apnr.2013.08.002. [PubMed: 24050917].
  • 26. Napolitano F, Napolitano P, Angelillo IF, Collaborative Working G. Medication adherence among patients with chronic conditions in Italy. Eur J Public Health. 2016;26(1):48-52. doi: 10.1093/eurpub/ckv147. [PubMed: 26268628].
  • 27. Zhao S, Zhao H, Wang L, Du S, Qin Y. Education is critical for medication adherence in patients with coronary heart disease. Acta Cardiol. 2015;70(2):197-204. doi: 10.2143/AC.70.2.3073511. [PubMed: 26148380].
  • 28. Sweileh WM, Zyoud SH, Abu Nab'a RJ, Deleq MI, Enaia MI, Nassar SM, et al. Influence of patients' disease knowledge and beliefs about medicines on medication adherence: Findings from a cross-sectional survey among patients with type 2 diabetes mellitus in Palestine. BMC Public Health. 2014;14:94. doi: 10.1186/1471-2458-14-94. [PubMed: 24479638]. [PubMed Central: PMC3909379].
  • 29. Grant RW, O'Leary KM, Weilburg JB, Singer DE, Meigs JB. Impact of concurrent medication use on statin adherence and refill persistence. Arch Intern Med. 2004;164(21):2343-8. doi: 10.1001/archinte.164.21.2343. [PubMed: 15557413].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments